CELH
Celsius Holdings, Inc.
CELH has the edge over DDL overall, supported by stronger fundamentals and stronger valuation.
DDL
Dingdong (Cayman) Limited
DDL trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
DDL Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Under pressure | |
| Strong |
DDL's balance sheet is currently strong, and its profitability is stable, but its revenue and cash flow are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
DDL PE Valuation
DDL has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
DDL Forward outlook
There aren't enough analyst estimates for DDL to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
DDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.37 | +37% |
| Q1 2026 | $0.26 | 0% |
| Q4 2025 | $0.15 | -44% |
| Q3 2025 | $0.19 | -5% |
| Q2 2025 | $0.27 | +286% |
| Q1 2025 | $0.26 | +$0.30 |
| Q4 2024 | $0.27 | +$0.37 |
| Q3 2024 | $0.20 | +$0.24 |
DDL has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over DDL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over DDL on profitability, with a higher operating margin.
DDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11M | -99% |
| Q1 2026 | $20.8M | -97% |
| Q4 2025 | $936.8M | +5.7% |
| Q3 2025 | $999.8M | +1.9% |
| Q2 2025 | $896.8M | +6.7% |
| Q1 2025 | $822.2M | +9.1% |
| Q4 2024 | $886.2M | +18% |
| Q3 2024 | $981.2M | +27% |
DDL's revenue is shrinking: $11M last quarter, down 99% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -96% | -97 points |
| Q1 2026 | -49% | -49 points |
| Q4 2025 | 0.2% | -0.9 points |
| Q3 2025 | 0.9% | -0.8 points |
| Q2 2025 | 1.4% | +0.4 points |
| Q1 2025 | -0.4% | -0.2 points |
| Q4 2024 | 1% | +1.5 points |
| Q3 2024 | 1.7% | +1.9 points |
DDL's operating margin was −96% last quarter, down 97 points from the same quarter a year ago, near the bottom of its range since 2020.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
DDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $19M | +25% |
| Q1 2026 | $22M | +72% |
| Q4 2025 | $4M | -71% |
| Q3 2025 | $21.7M | -64% |
| Q2 2025 | $15.2M | -59% |
| Q1 2025 | $12.8M | -10% |
| Q4 2024 | $13.9M | +154% |
| Q3 2024 | $59.7M | +206% |
DDL has the edge over CELH on cash flow, with stronger typical year-over-year growth.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
DDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +71.2K shares |
| 1 year | -3.1% | -6.9M shares |
| 3 years | +50% | +72.4M shares |
| 5 years | +32% | +52.7M shares |
| Available history | +104% | +110M shares |
DDL has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1.3M |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $4.6M |
| Q3 2024 | — |
DDL spent $1M buying back its own shares over the past year, down 71% from the year before.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
DDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -15.8x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 3.4x | Elevated |
| Q4 2024 | 4.5x | High |
| Q3 2024 | 4.7x | High |
DDL has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
DDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 9.9 | Oversold |
DDL's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
DDL PE vs Consumer Defensive Sector
DDL has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over DDL on trend strength, trading above more of its moving averages.
DDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.02 | 6.4% below |
| 20 week MA | $2.18 | 13% below |
| 50 week MA | $2.41 | 22% below |
| 100 week MA | $2.45 | 23% below |
| 200 week MA | $2.51 | 25% below |
DDL is in a downtrend: it's below all five of its weekly moving averages, and 25% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over DDL on returns for 2026, with the stronger performance.
DDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $28.8 | $13.3 | -54% |
| 2022 | $13.3 | $4.47 | -66% |
| 2023 | $4.47 | $1.50 | -66% |
| 2024 | $1.50 | $3.76 | +151% |
| 2025 | $3.76 | $2.88 | -23% |
| 2026 YTD | $2.88 | $1.89 | -34% |
DDL's yearly returns have swung widely, from +151% in 2024 to −66% in 2023. It's down 34% so far in 2026.